Mumtaz Score for Readmission in Cirrhosis

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years

حداقل ۱۰۰ — حداکثر ۱۶۰ • واحد: mEq/L

حداقل ۱ — حداکثر ۶ • واحد: g/dL

حداقل ۱ — حداکثر ۳۶۵ • واحد: days

حداقل ۰ — حداکثر ۲۰ • واحد: admissions

حداقل ۶ — حداکثر ۴۰ • واحد: points

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
readmission risk
—%
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–15
  • Moderate Risk15–30
  • High Risk30–50
  • Very High Risk50–100
Direct Clinical Answer

The Mumtaz Score for Readmission in Cirrhosis calculates predicting 30-day readmission risk in patients with cirrhosis following hospital discharge. Key inputs include age. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Predicts 30-day readmission risk in patients with cirrhosis following hospital discharge. This prognostic tool helps clinicians identify high-risk patients who may benefit from enhanced discharge planning, close outpatient follow-up, and preventive interventions to reduce readmission rates.

Clinical Indication

The Mumtaz Score for Readmission in Cirrhosis is indicated for bedside clinical practice to support Predicts 30-day readmission risk in patients with cirrhosis following hospital discharge. This prognostic tool helps clinicians identify high-risk patients who may benefit from enhanced discharge planning, close outpatient follow-up, and preventive interventions to reduce readmission rates.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: The model showed good discrimination (C-statistic 0.68-0.72) and calibration in validation studies.

Formula & Variables:

Logistic regression model incorporating age, serum sodium, albumin, length of stay, previous admissions, MELD score, hepatic encephalopathy, and ascites with specific coefficients to calculate 30-day readmission probability

Input Parameters

NameTypeRequiredDescription
ageintegerYesPatient age in years(years)
serum_sodiumfloatYesSerum sodium level. Hyponatremia is associated with increased readmission risk in cirrhosis patients(mEq/L)
albuminfloatYesSerum albumin level. Lower albumin indicates poor synthetic liver function and higher readmission risk(g/dL)
length_of_stayintegerYesLength of current hospital stay in days. Longer stays may indicate more severe illness(days)
previous_admissions_6_monthsintegerYesNumber of hospital admissions in the previous 6 months. Prior admissions are strong predictors of readmission(admissions)
meld_scoreintegerYesModel for End-Stage Liver Disease (MELD) score at discharge. Higher MELD scores indicate more severe liver disease(points)
hepatic_encephalopathystringYesPresence of hepatic encephalopathy during current admission. HE increases readmission risk
ascitesstringYesPresence of ascites during current admission. Ascites complications increase readmission risk

Score Interpretation & Guidance

RangeStageDescription
0–15Low RiskLow 30-day readmission risk
15–30Moderate RiskModerate 30-day readmission risk
30–50High RiskHigh 30-day readmission risk
50–100Very High RiskVery high 30-day readmission risk

Evidence-Based References (EBM)

  • Mumtaz K, Issak A, Porter K, Kelly S, Hanje J, Michaels AJ, et al. Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic Patients: A Model Based on the Administrative Database. Hepatology. 2019;70(2):630-639. doi: 10.1002/hep.30274.DOI: 10.1002/hep.30274
  • Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR Jr, Nguyen JH, et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol. 2011;9(3):254-9. doi: 10.1016/j.cgh.2010.10.035.DOI: 10.1016/j.cgh.2010.10.035
  • Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107(2):247-52. doi: 10.1038/ajg.2011.314.DOI: 10.1038/ajg.2011.314

Related calculators